These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 20069634

  • 21. Human papillomavirus DNA, HPV L1 capsid protein and p16INK4a protein as markers to predict cervical lesion progression.
    Hu H, Zhao J, Yu W, Zhao J, Wang Z, Jin L, Yu Y, Han L, Wang L, Zhu H, Li F.
    Arch Gynecol Obstet; 2019 Jan; 299(1):141-149. PubMed ID: 30390110
    [Abstract] [Full Text] [Related]

  • 22. [Significance of p16/Ki-67 double immunocytochemical staining in cervical cytology ASCUS, LSIL, and ASC-H].
    Wu Y, Zhao J, Hu J, Wu XW, Zhu LR.
    Zhonghua Fu Chan Ke Za Zhi; 2017 Nov 25; 52(11):734-739. PubMed ID: 29179267
    [Abstract] [Full Text] [Related]

  • 23. Immunohistochemical detection of p16INK4a in liquid-based cytology specimens on cell block sections.
    Liu H, Shi J, Wilkerson M, Huang Y, Meschter S, Dupree W, Lin F.
    Cancer; 2007 Apr 25; 111(2):74-82. PubMed ID: 17330305
    [Abstract] [Full Text] [Related]

  • 24. [Clinical value of p16INK4a immunocytochemistry in cervical cancer screening].
    Song FB, Du H, Xiao AM, Wang C, Huang X, Yan PS, Liu ZH, Qu XF, Belinson JEROMEL, Wu RF.
    Zhonghua Fu Chan Ke Za Zhi; 2020 Nov 25; 55(11):784-790. PubMed ID: 33228350
    [Abstract] [Full Text] [Related]

  • 25. Diagnostic Accuracy of Conventional Cell Blocks Along with p16INK4 and Ki67 Biomarkers as Triage Tests in Resource-poor Organized Cervical Cancer Screening Programs.
    Desai F, Singh LS, Majachunglu G, Kamei H.
    Asian Pac J Cancer Prev; 2019 Mar 26; 20(3):917-923. PubMed ID: 30912415
    [Abstract] [Full Text] [Related]

  • 26. Immunochemical analysis of HPV L1 capsid protein and p16 protein in liquid-based cytology samples from uterine cervical lesions.
    Yoshida T, Sano T, Kanuma T, Owada N, Sakurai S, Fukuda T, Nakajima T.
    Cancer; 2008 Apr 25; 114(2):83-8. PubMed ID: 18300235
    [Abstract] [Full Text] [Related]

  • 27. Determinants of p16/Ki-67 adequacy and positivity in HPV-positive women from a screening population.
    Benevolo M, Mancuso P, Allia E, Gustinucci D, Bulletti S, Cesarini E, Carozzi FM, Confortini M, Bisanzi S, Rubino T, Rollo F, Marchi N, Farruggio A, Pusiol T, Venturelli F, Giorgi Rossi P, New Technologies for Cervical Cancer 2 (NTCC2) Working Group.
    Cancer Cytopathol; 2021 May 25; 129(5):383-393. PubMed ID: 33142029
    [Abstract] [Full Text] [Related]

  • 28. Comparison of the sensitivity and specificity of p16/Ki-67 dual staining and HPV DNA testing of abnormal cervical cytology in the detection of histology proven cervical intraepithelial neoplasia grade 2 and above (CIN 2+).
    Tay TKY, Lim KL, Hilmy MH, Thike AA, Goh ST, Song LH, Hwang JSG, Mantoo S.
    Malays J Pathol; 2017 Dec 25; 39(3):257-265. PubMed ID: 29279588
    [Abstract] [Full Text] [Related]

  • 29. Immunohistochemical detection of human papillomavirus capsid proteins L1 and L2 in squamous intraepithelial lesions: potential utility in diagnosis and management.
    Yemelyanova A, Gravitt PE, Ronnett BM, Rositch AF, Ogurtsova A, Seidman J, Roden RB.
    Mod Pathol; 2013 Feb 25; 26(2):268-74. PubMed ID: 22996373
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Utility of human papillomavirus L1 capsid protein and HPV test as prognostic markers for cervical intraepithelial neoplasia 2+ in women with persistent ASCUS /LSIL cervical cytology.
    Ki EY, Park JS, Lee A, Kim TJ, Jin HT, Seo YB, Gen Y, Park MY, Lee SJ.
    Int J Med Sci; 2019 Feb 25; 16(8):1096-1101. PubMed ID: 31523171
    [Abstract] [Full Text] [Related]

  • 33. TOP2A/MCM2, p16INK4a, and cyclin E1 expression in liquid-based cytology: a biomarkers panel for progression risk of cervical premalignant lesions.
    Del Moral-Hernández O, Hernández-Sotelo D, Alarcón-Romero LDC, Mendoza-Catalán MA, Flores-Alfaro E, Castro-Coronel Y, Ortiz-Ortiz J, Leyva-Vázquez MA, Ortuño-Pineda C, Castro-Mora W, Illades-Aguiar B.
    BMC Cancer; 2021 Jan 07; 21(1):39. PubMed ID: 33413211
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Clinical value of fully automated p16/Ki-67 dual staining in the triage of HPV-positive women in the Norwegian Cervical Cancer Screening Program.
    Ovestad IT, Dalen I, Hansen E, Loge JL, Dybdahl BM, Dirdal MB, Moltu P, Berland JM.
    Cancer Cytopathol; 2017 Apr 07; 125(4):283-291. PubMed ID: 27918650
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Interobserver reproducibility and accuracy of p16/Ki-67 dual-stain cytology in cervical cancer screening.
    Wentzensen N, Fetterman B, Tokugawa D, Schiffman M, Castle PE, Wood SN, Stiemerling E, Poitras N, Lorey T, Kinney W.
    Cancer Cytopathol; 2014 Dec 07; 122(12):914-20. PubMed ID: 25132656
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Diagnostic value of p16/mcm2 dual staining in cervical intraepithelial neoplasia and its association with high-risk HPV infection].
    Wang HR, Liao GD, Jiang Y, Li YC, Qiao YL, Chen W.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Sep 10; 38(9):1241-1245. PubMed ID: 28910940
    [Abstract] [Full Text] [Related]

  • 40. Utility of p16, Ki-67, and HPV test in diagnosis of cervical intraepithelial neoplasia and atrophy in women older than 50 years with 3- to 7-year follow-up.
    Jackson JA, Kapur U, Erşahin Ç.
    Int J Surg Pathol; 2012 Apr 10; 20(2):146-53. PubMed ID: 22104735
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.